Mouse Anti-EHMT1 Recombinant Antibody (CBT3168) (V2LY-0625-LY2072)

Name: Mouse Anti-EHMT1 Recombinant Antibody (CBT3168)
SKU: V2LY-0625-LY2072
Rating: 5 (1 reviews)

See all EHMT1 antibodies

Compare Online Inquiry

Tested Data

Mouse Anti-EHMT1 Recombinant Antibody (CBT3168) (V2LY-0625-LY2072) in WB

Datasheet

SDS

Request for COA

Datasheet Target References Q & As Review & reward Protocols Associated Products

Basic Information

Host Animal

Mouse

Clone

CBT3168

Application

Immunogen

Purified recombinant fragment of GLP expressed in E. Coli.

Host Species

Mouse

Specificity

Human

Antibody Isotype

IgG1

Clonality

Monoclonal Antibody

Application Notes

Application	Note
WB	1:500-1:2,000
ELISA	1:10,000

Formulations & Storage [For reference only, actual COA shall prevail!]

Format

Supernatant

Preservative

Sodium azide

Concentration

Batch dependent

Storage

Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freezethaw cycles.

More Infomation

Target

Full Name

Euchromatic Histone Lysine Methyltransferase 1

Entrez Gene ID

79813

UniProt ID

Q9H9B1

Research Area

Histone methyltransferase that specifically mono- and dimethylates 'Lys-9' of histone H3 (H3K9me1 and H3K9me2, respectively) in euchromatin. H3K9me represents a specific tag for epigenetic transcriptional repression by recruiting HP1 proteins to methylated histones. Also weakly methylates 'Lys-27' of histone H3 (H3K27me). Also required for DNA methylation, the histone methyltransferase activity is not required for DNA methylation, suggesting that these 2 activities function independently. Probably targeted to histone H3 by different DNA-binding proteins like E2F6, MGA, MAX and/or DP1. During G0 phase, it probably contributes to silencing of MYC- and E2F-responsive genes, suggesting a role in G0/G1 transition in cell cycle. In addition to the histone methyltransferase activity, also methylates non-histone proteins: mediates dimethylation of 'Lys-373' of p53/TP53. Represses the expression of mitochondrial function-related genes, perhaps by occupying their promoter regions, working in concert with probable chromatin reader BAZ2B (By similarity).

Biological Process

Chromatin organization Source: UniProtKB
DNA methylation Source: UniProtKB
Histone methylation Source: UniProtKB
Negative regulation of transcription, DNA-templated Source: UniProtKB
Negative regulation of transcription by RNA polymerase II Source: Ensembl
Peptidyl-lysine dimethylation Source: UniProtKB
Peptidyl-lysine monomethylation Source: UniProtKB
Positive regulation of cold-induced thermogenesis Source: YuBioLab
Regulation of embryonic development Source: UniProtKB
Response to fungicide Source: Ensembl

Cellular Location

Nucleus; Chromosome. Associates with euchromatic regions.

Involvement in disease

Kleefstra syndrome 1 (KLEFS1):
The disease is caused by variants affecting the gene represented in this entry. The syndrome can be either caused by intragenic EHMT1 mutations leading to haploinsufficiency of the EHMT1 gene or by a submicroscopic 9q34.3 deletion. Although it is not known if and to what extent other genes in the 9q34.3 region contribute to the syndrome observed in deletion cases, EHMT1 seems to be the major determinant of the core disease phenotype (PubMed:19264732). A form of Kleefstra syndrome, an autosomal dominant disease characterized by variable mental retardation, psychomotor developmental delay, seizures, behavioral abnormalities, and facial dysmorphisms. KLEFS1 patients additionally manifest brachy(micro)cephaly, congenital heart defects, and urogenital defects.

Nachiyappan, A., Gupta, N., & Taneja, R. (2022). EHMT1/EHMT2 in EMT, cancer stemness and drug resistance: emerging evidence and mechanisms. The FEBS Journal, 289(5), 1329-1351.

Ang, G. C. K., Gupta, A., Surana, U., Yap, S. X. L., & Taneja, R. (2022). Potential Therapeutics Targeting Upstream Regulators and Interactors of EHMT1/2. Cancers, 14(12), 2855.

Nachiyappan, A., Soon, J. L. J., Lim, H. J., Lee, V. K., & Taneja, R. (2022). EHMT1 promotes tumor progression and maintains stemness by regulating ALDH1A1 expression in alveolar rhabdomyosarcoma. The Journal of Pathology, 256(3), 349-362.

Huang, Q., Xiong, H., Tao, Z., Yue, F., & Xiao, N. (2021). Clinical phenotypes and molecular findings in ten Chinese patients with Kleefstra Syndrome Type 1 due to EHMT1 defects. European Journal of Medical Genetics, 64(9), 104289.

Lee, J., Kim, K., Ryu, T. Y., Jung, C. R., Lee, M. S., Lim, J. H., ... & Cho, H. S. (2021). EHMT1 knockdown induces apoptosis and cell cycle arrest in lung cancer cells by increasing CDKN1A expression. Molecular oncology, 15(11), 2989-3002.

Wang, Z. J., Zhong, P., Ma, K., Seo, J. S., Yang, F., Hu, Z., ... & Yan, Z. (2020). Amelioration of autism-like social deficits by targeting histone methyltransferases EHMT1/2 in Shank3-deficient mice. Molecular psychiatry, 25(10), 2517-2533.

Meng, T. G., Zhou, Q., Ma, X. S., Liu, X. Y., Meng, Q. R., Huang, X. J., ... & Sun, Q. Y. (2020). PRC2 and EHMT1 regulate H3K27me2 and H3K27me3 establishment across the zygote genome. Nature communications, 11(1), 1-12.

Bonati, M. T., Castronovo, C., Sironi, A., Zimbalatti, D., Bestetti, I., Crippa, M., ... & Finelli, P. (2019). 9q34. 3 microduplications lead to neurodevelopmental disorders through EHMT1 overexpression. neurogenetics, 20(3), 145-154.

Watson, Z. L., Yamamoto, T. M., McMellen, A., Kim, H., Hughes, C. J., Wheeler, L. J., ... & Bitler, B. G. (2019). Histone methyltransferases EHMT1 and EHMT2 (GLP/G9A) maintain PARP inhibitor resistance in high-grade serous ovarian carcinoma. Clinical epigenetics, 11(1), 1-16.

Zheng, Y., Liu, A., Wang, Z. J., Cao, Q., Wang, W., Lin, L., ... & Yan, Z. (2019). Inhibition of EHMT1/2 rescues synaptic and cognitive functions for Alzheimer’s disease. Brain, 142(3), 787-807.

Ask a question We look forward to hearing from you.

0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Have you used Mouse Anti-EHMT1 Recombinant Antibody (CBT3168)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon

$30 eGift Card
Submit a review

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols

Related Products

Human Recombinant EHMT1, Active protein, GST Tag (CAT#: V2LY-0526-LY3813)

Mouse Anti-EHMT1 Recombinant Antibody (CBFYE-0623) (CAT#: V2LY-0425-LY1608)

Mouse Anti-EHMT1 Recombinant Antibody (B0422) (CAT#: V2LY-0425-LY1609)

Rabbit Anti-EHMT1 Recombinant Antibody (CP0553) (CAT#: V2LY-0425-LY1611)

Mouse Anti-EHMT1 Recombinant Antibody (2312) (CAT#: CBMAB-E1025-FY)

Mouse Anti-EHMT1 Recombinant Antibody (3G1) (CAT#: V2LY-0425-LY1610)

Mouse Anti-EHMT1 Recombinant Antibody (CBT470) (CAT#: V2LY-0625-LY3502)

Mouse Anti-EHMT1 Recombinant Antibody (CBFYE-0177) (CAT#: V2LY-0425-LY1607)

Isotype control

For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Request bulk or custom quote Second antibody and isotype control

Contact us

Tel: (USA)
(UK)
Fax:

Global Locations

Email:

Online Inquiry